Energy infrastructure is also included in the ceasefire deal, which is bearish for oil markets.

image for news Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Pulls Back As Russia And Ukraine Agree To Ceasefire In Black Sea

SAN FRANCISCO, March 25, 2025 (GLOBE NEWSWIRE) -- On February 27, 2025, investors saw the price of their shares of Viatris Inc. (NASDAQ: VTRS) tumble over 15% after the company disclosed an anticipated adverse 2025 monetary impact from the U.S. FDA's recent December 2024 determination concerning the company's oral dose manufacturing facility in Indore, India. Hagens Berman is investigating possible misconduct concerning the timing of Viatris' disclosures and urges investors who purchased Viatris shares and suffered substantial losses to submit your losses now.

image for news Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman

Market Navigator: Time to step back from Apple? — Neutral

AAPL   CNBC Television — March 25, 2025

Tony Zhang, OptionsPlay chief strategist, joins 'Power Lunch' to discuss whether it's a good time to step back from Apple.

image for news Market Navigator: Time to step back from Apple?

On Sunday, human genetics and biotechnology company 23andMe Holding Co ME voluntarily filed for Chapter 11 bankruptcy to enable a sale process to maximize its business value.

image for news 23andMe's Bankruptcy Sparks Privacy Concerns Over Genetic Database Of 15 Million Customers

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=138610&wire=1 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Monolithic Power Systems Inc. (MPWR)

SAN FRANCISCO, CA / ACCESS Newswire / March 25, 2025 / A securities class action has been filed against Zynex, Inc. (NASDAQ:ZYXI), a medical device manufacturer that produces and markets electrotherapy devices for use in pain management and physical rehabilitation,after it reported dismal Q4 and FY 2024 financial results which sent the price of Zynex shares down $3.59 (-51%) on March 12, 2025. The suit, captioned Tuncel v.

image for news Zynex, Inc. (ZYXI) Craters 51% On Possible Accounting Issues, Securities Class Action Filed - Hagens Berman

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (NYSE:SBS ) Q4 2024 Earnings Conference Call March 25, 2025 12:00 PM ET Company Participants Thiago Levy - Investor Relations Director Daniel Szlak - Chief Financial Officer and Investor Relations Officer Carlos Augusto Leone Piani - Chief Executive Officer Operator Good morning and welcome to SABESP Fourth Quarter of 2024 Earnings Presentation. With us here today are Carlos Piani, CEO; Daniel Szlak, CFO; and Thiago Levy, Investor Relations.

image for news Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Q4 2024 Earnings Call Transcript

NEW YORK CITY, NY / ACCESS Newswire / March 25, 2025 / WHY: New York, N.Y., March 25, 2025.

image for news ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

23andMe has officially filed for Chapter 11 bankruptcy protection, which means a new company could acquire its genetic database. DNA data is particularly sensitive, and bad actors can use it to carry out numerous crimes.

image for news With 23andMe entering bankruptcy, here's how to delete your genetic data

Tesla Pauses FSD Trial in China to Seek Regulatory Approval — Positive

TSLA   Zacks Investment Research — March 25, 2025

TSLA temporarily pauses a limited-time free trial of its FSD service in China to secure newly introduced regulatory approval.

image for news Tesla Pauses FSD Trial in China to Seek Regulatory Approval

Ford's 1.3M F-150 Trucks Under Scrutiny in US Due to a Defect in Gear — Negative

F   Zacks Investment Research — March 25, 2025

F is under investigation for nearly 1.3 million F-150 trucks in the United States due to reports of sudden gear downshifts that can temporarily lock the rear wheels.

image for news Ford's 1.3M F-150 Trucks Under Scrutiny in US Due to a Defect in Gear

Earnings Momentum is Surging in This Industry — Positive

HCI  NWG  OPFI   Zacks Investment Research — March 25, 2025

The Financial sector currently dominates the Zacks #1 Rank list, with 81 stocks, more than double the count of the next closest sector, Computers, which has 32. Analysts have been doling out huge upgrades to companies across the industry thanks to an improving regulatory environment and persistently high interest rates which improve margins.

image for news Earnings Momentum is Surging in This Industry

Morgan Stanley analyst Bob Jian Huang downgraded Brown & Brown, Inc. BRO to Equal-weight from Overweight and maintained a price forecast of $128.

image for news Brown & Brown Gets Downgraded But Analyst Still Vouches For Long-Term Growth

AGS Wins 2025 USA TODAY Top Workplaces USA Award — Neutral

AGS   GlobeNewsWire — March 25, 2025

LAS VEGAS, March 25, 2025 (GLOBE NEWSWIRE) -- AGS (NYSE: AGS), a leading supplier of high-performing slot, table, and interactive products and services to the global gaming industry, is excited to announce that it has been named a 2025 USA TODAY Top Workplaces USA Award winner. Recognized for its commitment to fostering an exceptional, people-first culture, AGS ranked in the Top 28% of companies in the 500-999 employee category, placing the company in the Top 100 of companies in this size category across America.

image for news AGS Wins 2025 USA TODAY Top Workplaces USA Award

Larry Tentarelli says he "wouldn't go all in on anything just yet," noting the SPX and NDX breaking their 200-day SMA as bearish for both indices. He believes the Trump administration's April 2nd deadline on tariff announcements could usher in a bull run.

image for news Tentarelli: Tariff Certainty "Bullish" for Markets, PLTR, BRK/B & RTX Rebound Leaders

D. Boral Capital analyst Jesse Sobelson reiterated a Buy rating on the shares of MicroVision Inc MVIS with a price forecast of $3.00.

image for news MicroVision's Strategic Moves And New CTO Drive Analyst Confidence, But Challenges Remain In Q4

AT&T is in talks to acquire Lumen Technologies' consumer fiber operations, Bloomberg News reported on Tuesday, according to people with knowledge of the matter.

image for news AT&T in talks to buy lumen's consumer fiber unit, Bloomberg News reports

AI Stock Trades Higher Than Industry at 6.65X P/S: Buy or Hold? — Neutral

AI   Zacks Investment Research — March 25, 2025

C3.ai faces intense competition and macroeconomic challenges despite strong demand for AI solutions and expanding partnerships.

image for news AI Stock Trades Higher Than Industry at 6.65X P/S: Buy or Hold?

ARM Stock Declines 10% in a Month: Buy or Wait for Further Fall? — Positive

ARM   Zacks Investment Research — March 25, 2025

Given the recent fall in Arm Holdings shares, we evaluate the stock's current position to determine whether it presents a good investment opportunity.

image for news ARM Stock Declines 10% in a Month: Buy or Wait for Further Fall?

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=138612&wire=1 or contact Joseph E. Levi, Esq.

image for news GSK plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - GSK